SG11201702490PA - Method for detecting cardiac failure patient, method for discrimination of cardiac disease, test reagent for cardiac failure, test kit for cardiac failure, device for detecting cardiac failure, and program for detecting cardiac failure - Google Patents
Method for detecting cardiac failure patient, method for discrimination of cardiac disease, test reagent for cardiac failure, test kit for cardiac failure, device for detecting cardiac failure, and program for detecting cardiac failureInfo
- Publication number
- SG11201702490PA SG11201702490PA SG11201702490PA SG11201702490PA SG11201702490PA SG 11201702490P A SG11201702490P A SG 11201702490PA SG 11201702490P A SG11201702490P A SG 11201702490PA SG 11201702490P A SG11201702490P A SG 11201702490PA SG 11201702490P A SG11201702490P A SG 11201702490PA
- Authority
- SG
- Singapore
- Prior art keywords
- cardiac failure
- detecting
- cardiac
- failure
- discrimination
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014208914 | 2014-10-10 | ||
| PCT/JP2015/078851 WO2016056664A1 (ja) | 2014-10-10 | 2015-10-09 | 心不全患者の検出方法、心疾患の識別方法、心不全の検査試薬、心不全の検査キット、心不全を検出するための装置及び心不全を検出するためのプログラム |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201702490PA true SG11201702490PA (en) | 2017-04-27 |
Family
ID=55653268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201702490PA SG11201702490PA (en) | 2014-10-10 | 2015-10-09 | Method for detecting cardiac failure patient, method for discrimination of cardiac disease, test reagent for cardiac failure, test kit for cardiac failure, device for detecting cardiac failure, and program for detecting cardiac failure |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10823741B2 (de) |
| EP (1) | EP3206032B1 (de) |
| JP (1) | JP6682445B2 (de) |
| CN (1) | CN106716135B (de) |
| SG (1) | SG11201702490PA (de) |
| WO (1) | WO2016056664A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2019065747A1 (ja) | 2017-09-26 | 2021-01-28 | 国立大学法人大阪大学 | 抗ｃｋａｐ４モノクローナル抗体 |
| JP7009977B2 (ja) * | 2017-12-25 | 2022-01-26 | 国立大学法人東海国立大学機構 | 被検体の血中ｖｅｇｆ－ａに関する測定値を用いた心疾患の重症度及び予後予測を行うための方法、装置及びコンピュータプログラム |
| CN114720700A (zh) * | 2022-05-07 | 2022-07-08 | 浙江大学 | 检测抗细胞骨架相关蛋白4-IgG自身抗体的试剂在制备检测血管内皮损伤试剂盒的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2372282T3 (es) * | 2003-05-12 | 2012-01-18 | F. Hoffmann-La Roche Ag | Método para detectar probnp con un anticuerpo monoclonal que fija los aminoácidos 38-43. |
| EP1722232A1 (de) * | 2005-05-09 | 2006-11-15 | F.Hoffmann-La Roche Ag | Vorrichtungen und Verfahren zur Diagnose oder zur Früherkennung der kardialen Dysfunktion |
| CA2735716A1 (en) * | 2008-09-12 | 2010-03-18 | Dako Denmark A/S | Prostate cancer biomarker |
| US9469876B2 (en) * | 2010-04-06 | 2016-10-18 | Caris Life Sciences Switzerland Holdings Gmbh | Circulating biomarkers for metastatic prostate cancer |
| US8999659B2 (en) * | 2010-10-20 | 2015-04-07 | The Regents Of The University Of California | Body fluid BIN1 as a marker of cardiac health |
| US20120219943A1 (en) * | 2011-02-03 | 2012-08-30 | Abbott Laboratories | Methods of prognosis and diagnosis in chronic heart failure |
| CN103492590A (zh) * | 2011-02-22 | 2014-01-01 | 卡里斯生命科学卢森堡控股有限责任公司 | 循环生物标志物 |
| US9886545B2 (en) * | 2011-03-02 | 2018-02-06 | Berg Llc | Interrogatory cell-based assays and uses thereof |
| EP2786154B1 (de) * | 2011-12-01 | 2017-11-01 | Roche Diagnostics GmbH | Nt-pro-anp und nt-pro-bnp zur diagnose eines schlaganfalls |
| EP2626705A1 (de) * | 2012-02-13 | 2013-08-14 | Institut d'Investigacions Biomédiques August Pi i Sunyer | Verwendung einer löslichen Form von AXL bei der Diagnose und/oder Prognose des Syndroms der Herzinsuffizienz |
| EP2730923A1 (de) * | 2012-11-09 | 2014-05-14 | Roche Diagniostics GmbH | NTproBNP- und cTnT-basierte Therapieanleitung bei Herzversagen |
-
2015
- 2015-10-09 CN CN201580052417.5A patent/CN106716135B/zh active Active
- 2015-10-09 JP JP2016553179A patent/JP6682445B2/ja active Active
- 2015-10-09 WO PCT/JP2015/078851 patent/WO2016056664A1/ja active Application Filing
- 2015-10-09 EP EP15849135.7A patent/EP3206032B1/de active Active
- 2015-10-09 SG SG11201702490PA patent/SG11201702490PA/en unknown
-
2017
- 2017-03-27 US US15/470,336 patent/US10823741B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016056664A1 (ja) | 2016-04-14 |
| JP6682445B2 (ja) | 2020-04-15 |
| US10823741B2 (en) | 2020-11-03 |
| CN106716135B (zh) | 2019-03-15 |
| EP3206032A4 (de) | 2018-02-28 |
| CN106716135A (zh) | 2017-05-24 |
| JPWO2016056664A1 (ja) | 2017-07-27 |
| EP3206032B1 (de) | 2019-02-27 |
| EP3206032A1 (de) | 2017-08-16 |
| US20170205428A1 (en) | 2017-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1254633A1 (zh) | 用於分析樣品，尤其是血液，的裝置和系統以及使用它的方法 | |
| GB2552267B (en) | Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results | |
| HK1257999A1 (zh) | 用於臨床應用的分析物收集、提取、濃縮和檢測的方法和裝置 | |
| IL258358A (en) | Quantitative cardiac examination | |
| HK1244876A1 (zh) | 用於st2心臟生物標誌物的測試裝置和方法 | |
| HK1214671A1 (zh) | 輔助疾病診療的分析系統、裝置及方法 | |
| GB2543728B (en) | Medical kit and method for processing a biological sample | |
| PL3171765T3 (pl) | Zbieranie i analiza danych do celów diagnostycznych | |
| SG11201609288YA (en) | Fully-automatic immunofluorescence quantitative analysis device and detection method | |
| AP2016009549A0 (en) | Methods for increasing red blood cell levels and treating sickle-cell disease | |
| EP3186397C0 (de) | Verwendung von biomarkern zirkulierender zellen im blut zum nachweis und zur diagnose von krankheiten und verfahren zur isolierung davon | |
| EP3111216A4 (de) | Verfahren und vorrichtung zur bestimmung von gesundheitsmarkern durch die analyse von blut | |
| EP3173027A4 (de) | Verfahren zur beurteilung von herzversagen und diagnosevorrichtung | |
| EP3321675A4 (de) | Bluttestkit und blutanalyseverfahren | |
| GB2540699B (en) | Impedance analysis for fluid discrimination and monitoring | |
| EP3133390A4 (de) | Blutstatusanalysevorrichtung, blutstatusanalysesystem, blutstatusanalyseverfahren und programm | |
| PT3258266T (pt) | Kit de reagentes usado para detetar gastrina-17, método de preparação e aplicação de kit de reagentes | |
| SG11201703202YA (en) | Method and system for detection of disease agents in blood | |
| EP3321676A4 (de) | Bluttestkit und blutanalyseverfahren | |
| EP3217877A4 (de) | Vorrichtung und verfahren zur messung des sauerstoffgehalts in blut und/oder zur erkennung von gehirnblutergüssen | |
| HK1214649A1 (zh) | 體外診斷分析方法和系統 | |
| HK1245049A1 (zh) | 用於無創地確定血糖濃度的方法 | |
| SG11201702490PA (en) | Method for detecting cardiac failure patient, method for discrimination of cardiac disease, test reagent for cardiac failure, test kit for cardiac failure, device for detecting cardiac failure, and program for detecting cardiac failure | |
| EP3016587A4 (de) | Vorrichtung und verfahren zur beurteilung, diagnostizierung und/oder überwachung der gesundheit des herzens | |
| HK1259077A1 (zh) | 使用用於bcg療法的生物標記來治療及診斷疾病的方法 |